Natura & Co, the parent company of renowned brands like Natura and Avon, has made an announcement regarding its decision to withdraw its American Depositary Shares (ADSs) from the New York Stock Exchange (NYSE). This strategic move is aimed at streamlining operations and refocusing on the company’s primary market in Brazil.
The Board of Directors of Natura & Co has approved this plan in response to the majority of trading activity being concentrated on the B3 exchange in São Paulo. The declining trade volume of Natura &Co’s ADSs on the NYSE has led to the conclusion that maintaining the listing no longer provides significant benefits.
It is expected that trading of the company’s ADSs on the NYSE will be suspended around February 9, 2024, following a 10-day period subsequent to the filing of Form 25 with the U.S. Securities and Exchange Commission. Natura & Co has not made arrangements for the ADRs to be listed or quoted on any other U.S. securities exchange or quotation medium.
Fabio Barbosa, CEO of Natura & Co, emphasized that this decision aligns with the company’s long-term business strategy. He expressed gratitude to the investors of Natura & Co’s ADRs and encouraged them to continue their support through the company’s B3 market shares. Barbosa assured that despite the delisting, Natura & Co remains committed to maintaining high standards of disclosure.
It is worth noting that Natura & Co completed the sale of Aesop and The Body Shop in 2023, and sources close to the matter have revealed that Natura & Co has been exploring the sale of most of the international business of its Avon brand. If Natura & Co successfully sells Avon, then only Natura single brand remains under its banner.
